| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| beta-Lactamases | 101 | 2025 | 212 | 22.050 |
Why?
|
| Escherichia coli | 57 | 2024 | 1031 | 8.320 |
Why?
|
| beta-Lactamase Inhibitors | 28 | 2023 | 62 | 7.690 |
Why?
|
| Bacterial Proteins | 45 | 2024 | 924 | 6.850 |
Why?
|
| Ceftazidime | 18 | 2024 | 50 | 4.630 |
Why?
|
| Anti-Bacterial Agents | 42 | 2025 | 2577 | 4.550 |
Why?
|
| Models, Molecular | 49 | 2023 | 1147 | 3.940 |
Why?
|
| Catalytic Domain | 22 | 2025 | 180 | 3.900 |
Why?
|
| Carbapenems | 11 | 2023 | 43 | 3.310 |
Why?
|
| Peptide Library | 14 | 2021 | 61 | 3.260 |
Why?
|
| beta-Lactam Resistance | 15 | 2025 | 49 | 3.010 |
Why?
|
| Klebsiella pneumoniae | 8 | 2024 | 88 | 2.830 |
Why?
|
| Norovirus | 11 | 2025 | 348 | 2.640 |
Why?
|
| Escherichia coli Proteins | 8 | 2023 | 316 | 2.440 |
Why?
|
| Cephalosporins | 14 | 2025 | 143 | 2.390 |
Why?
|
| Amino Acid Substitution | 19 | 2024 | 415 | 2.350 |
Why?
|
| Kinetics | 36 | 2021 | 1323 | 2.320 |
Why?
|
| Drug Resistance, Bacterial | 8 | 2023 | 384 | 2.180 |
Why?
|
| Hydrolysis | 24 | 2024 | 161 | 2.150 |
Why?
|
| Amino Acid Sequence | 43 | 2021 | 2785 | 2.120 |
Why?
|
| Protein Binding | 37 | 2021 | 1852 | 1.980 |
Why?
|
| beta-Lactams | 15 | 2025 | 56 | 1.920 |
Why?
|
| Microbial Sensitivity Tests | 30 | 2025 | 834 | 1.810 |
Why?
|
| Substrate Specificity | 23 | 2023 | 313 | 1.690 |
Why?
|
| Mutagenesis, Site-Directed | 24 | 2020 | 329 | 1.570 |
Why?
|
| Crystallography, X-Ray | 16 | 2023 | 393 | 1.510 |
Why?
|
| Penicillins | 9 | 2023 | 153 | 1.440 |
Why?
|
| Streptomyces | 7 | 2021 | 14 | 1.430 |
Why?
|
| Ampicillin | 11 | 2023 | 57 | 1.410 |
Why?
|
| High-Throughput Nucleotide Sequencing | 6 | 2020 | 964 | 1.370 |
Why?
|
| Enzyme Inhibitors | 12 | 2015 | 606 | 1.290 |
Why?
|
| Mutation | 25 | 2024 | 6343 | 1.290 |
Why?
|
| Single-Chain Antibodies | 4 | 2020 | 45 | 1.240 |
Why?
|
| Evolution, Molecular | 8 | 2020 | 707 | 1.240 |
Why?
|
| Caliciviridae Infections | 8 | 2025 | 359 | 1.190 |
Why?
|
| Molecular Sequence Data | 42 | 2017 | 3960 | 1.130 |
Why?
|
| Catalysis | 12 | 2023 | 141 | 1.100 |
Why?
|
| Protein Structure, Tertiary | 14 | 2023 | 787 | 1.070 |
Why?
|
| Bacillus anthracis | 6 | 2017 | 40 | 1.030 |
Why?
|
| Protein Conformation | 16 | 2021 | 873 | 1.030 |
Why?
|
| Treponema pallidum | 8 | 2008 | 50 | 1.010 |
Why?
|
| Polymyxins | 2 | 2023 | 15 | 1.000 |
Why?
|
| Imipenem | 4 | 2023 | 9 | 0.960 |
Why?
|
| Mutagenesis | 15 | 2023 | 356 | 0.940 |
Why?
|
| Colistin | 2 | 2023 | 33 | 0.930 |
Why?
|
| Mutation, Missense | 5 | 2020 | 946 | 0.920 |
Why?
|
| Cefotaxime | 7 | 2023 | 39 | 0.900 |
Why?
|
| Bacteriophages | 3 | 2020 | 93 | 0.900 |
Why?
|
| Binding Sites | 25 | 2020 | 1378 | 0.900 |
Why?
|
| Mutant Proteins | 5 | 2012 | 120 | 0.900 |
Why?
|
| Glycine | 4 | 2016 | 172 | 0.890 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 3 | 2020 | 151 | 0.850 |
Why?
|
| Cell Surface Display Techniques | 2 | 2020 | 11 | 0.850 |
Why?
|
| Enzyme Stability | 10 | 2018 | 60 | 0.840 |
Why?
|
| Antibodies, Viral | 4 | 2020 | 1205 | 0.790 |
Why?
|
| Thermodynamics | 12 | 2020 | 146 | 0.790 |
Why?
|
| Cloning, Molecular | 16 | 2020 | 911 | 0.780 |
Why?
|
| Drug Resistance, Microbial | 10 | 2023 | 198 | 0.770 |
Why?
|
| Virion | 4 | 2017 | 151 | 0.770 |
Why?
|
| Drug Resistance | 1 | 2023 | 262 | 0.760 |
Why?
|
| Peptides | 5 | 2013 | 863 | 0.740 |
Why?
|
| Base Sequence | 27 | 2016 | 3153 | 0.720 |
Why?
|
| Genes, fos | 2 | 2020 | 15 | 0.710 |
Why?
|
| Suppression, Genetic | 3 | 2010 | 43 | 0.710 |
Why?
|
| Antigens, Viral | 2 | 2020 | 438 | 0.710 |
Why?
|
| Small Molecule Libraries | 2 | 2020 | 138 | 0.700 |
Why?
|
| Penicillin-Binding Proteins | 3 | 2020 | 14 | 0.690 |
Why?
|
| Antigens, Bacterial | 8 | 2012 | 312 | 0.680 |
Why?
|
| Genes, jun | 1 | 2020 | 7 | 0.680 |
Why?
|
| Recombinant Proteins | 12 | 2020 | 1433 | 0.670 |
Why?
|
| Protons | 1 | 2020 | 98 | 0.660 |
Why?
|
| Gastroenteritis | 4 | 2025 | 366 | 0.660 |
Why?
|
| Protein Interaction Maps | 1 | 2020 | 91 | 0.650 |
Why?
|
| Plasmids | 13 | 2020 | 529 | 0.630 |
Why?
|
| Protein Engineering | 3 | 2016 | 74 | 0.630 |
Why?
|
| Structure-Activity Relationship | 20 | 2021 | 607 | 0.620 |
Why?
|
| Biological Assay | 1 | 2020 | 111 | 0.620 |
Why?
|
| Protein Array Analysis | 5 | 2014 | 105 | 0.600 |
Why?
|
| Cephalosporin Resistance | 1 | 2018 | 17 | 0.600 |
Why?
|
| Protease Inhibitors | 5 | 2025 | 100 | 0.590 |
Why?
|
| Protein Interaction Mapping | 3 | 2020 | 94 | 0.590 |
Why?
|
| Urinary Tract Infections | 1 | 2022 | 314 | 0.560 |
Why?
|
| Zinc | 2 | 2012 | 141 | 0.540 |
Why?
|
| Nucleotide Motifs | 1 | 2016 | 48 | 0.530 |
Why?
|
| Serine | 2 | 2016 | 185 | 0.520 |
Why?
|
| Amino Acids | 5 | 2024 | 685 | 0.510 |
Why?
|
| Streptococcus pyogenes | 5 | 2020 | 79 | 0.500 |
Why?
|
| Nuclear Receptor Coactivator 3 | 5 | 2016 | 351 | 0.470 |
Why?
|
| Staphylococcus aureus | 3 | 2021 | 480 | 0.460 |
Why?
|
| Bacteriophage M13 | 4 | 2011 | 18 | 0.450 |
Why?
|
| Biological Evolution | 2 | 2015 | 254 | 0.450 |
Why?
|
| Asparagine | 2 | 2011 | 22 | 0.450 |
Why?
|
| Periplasmic Proteins | 2 | 2011 | 6 | 0.440 |
Why?
|
| Sequence Analysis, DNA | 8 | 2016 | 1830 | 0.440 |
Why?
|
| Open Reading Frames | 7 | 2020 | 220 | 0.440 |
Why?
|
| Genes, Bacterial | 9 | 2020 | 218 | 0.440 |
Why?
|
| Gene Library | 9 | 2012 | 224 | 0.420 |
Why?
|
| Binding Sites, Antibody | 3 | 2020 | 100 | 0.410 |
Why?
|
| Genomic Library | 4 | 2020 | 42 | 0.410 |
Why?
|
| Ampicillin Resistance | 6 | 2012 | 18 | 0.410 |
Why?
|
| Klebsiella Infections | 3 | 2023 | 62 | 0.400 |
Why?
|
| Virology | 1 | 2013 | 36 | 0.400 |
Why?
|
| Arginine | 2 | 2019 | 350 | 0.390 |
Why?
|
| Protein Structure, Secondary | 7 | 2020 | 256 | 0.380 |
Why?
|
| Acylation | 4 | 2021 | 17 | 0.370 |
Why?
|
| Orotidine-5'-Phosphate Decarboxylase | 1 | 2011 | 3 | 0.370 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2013 | 151 | 0.370 |
Why?
|
| Cysteine | 1 | 2012 | 143 | 0.370 |
Why?
|
| Sequence Alignment | 7 | 2020 | 631 | 0.360 |
Why?
|
| Antibodies, Monoclonal | 6 | 2020 | 1049 | 0.360 |
Why?
|
| Gram-Positive Bacteria | 2 | 2020 | 49 | 0.350 |
Why?
|
| Selection, Genetic | 3 | 2012 | 168 | 0.350 |
Why?
|
| Gram-Negative Bacteria | 2 | 2020 | 74 | 0.350 |
Why?
|
| Monobactams | 2 | 2023 | 7 | 0.330 |
Why?
|
| Molecular Structure | 9 | 2024 | 319 | 0.330 |
Why?
|
| Nuclear Receptor Coactivator 1 | 4 | 2015 | 244 | 0.320 |
Why?
|
| Antibodies, Bacterial | 6 | 2012 | 400 | 0.320 |
Why?
|
| DNA, Bacterial | 11 | 2014 | 488 | 0.310 |
Why?
|
| Protein Interaction Domains and Motifs | 3 | 2020 | 150 | 0.310 |
Why?
|
| Protein Domains | 3 | 2020 | 260 | 0.310 |
Why?
|
| Drug Discovery | 2 | 2021 | 180 | 0.310 |
Why?
|
| Protein Structure, Quaternary | 4 | 2015 | 102 | 0.310 |
Why?
|
| Rabbits | 8 | 2020 | 709 | 0.310 |
Why?
|
| Peptide Hydrolases | 4 | 2023 | 149 | 0.310 |
Why?
|
| Gene Expression Regulation, Bacterial | 3 | 2011 | 173 | 0.310 |
Why?
|
| Genetic Vectors | 8 | 2020 | 965 | 0.310 |
Why?
|
| Shewanella | 4 | 2010 | 10 | 0.310 |
Why?
|
| Codon | 4 | 2018 | 102 | 0.300 |
Why?
|
| Virus Replication | 3 | 2025 | 634 | 0.300 |
Why?
|
| Sequence Homology, Amino Acid | 6 | 2020 | 670 | 0.300 |
Why?
|
| Proline | 2 | 2008 | 80 | 0.300 |
Why?
|
| Epitopes | 4 | 2020 | 444 | 0.290 |
Why?
|
| DNA Primers | 7 | 2015 | 656 | 0.290 |
Why?
|
| Genome, Bacterial | 6 | 2008 | 213 | 0.290 |
Why?
|
| Proteome | 3 | 2008 | 282 | 0.280 |
Why?
|
| Penicillanic Acid | 4 | 2004 | 10 | 0.280 |
Why?
|
| DNA | 3 | 2023 | 1676 | 0.280 |
Why?
|
| Serratia marcescens | 1 | 2007 | 11 | 0.270 |
Why?
|
| Humans | 49 | 2025 | 133279 | 0.270 |
Why?
|
| Glutathione Transferase | 2 | 2005 | 153 | 0.270 |
Why?
|
| Leucine | 1 | 2008 | 312 | 0.270 |
Why?
|
| Cephalexin | 2 | 2021 | 7 | 0.270 |
Why?
|
| Syphilis | 3 | 2008 | 98 | 0.260 |
Why?
|
| Gene Expression | 5 | 2020 | 1608 | 0.260 |
Why?
|
| Transcription Factors | 5 | 2014 | 2720 | 0.260 |
Why?
|
| Ligands | 4 | 2017 | 571 | 0.260 |
Why?
|
| Cephalothin | 2 | 2020 | 6 | 0.260 |
Why?
|
| Streptococcal Infections | 3 | 2020 | 248 | 0.250 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 9 | 2015 | 835 | 0.250 |
Why?
|
| Epitope Mapping | 3 | 2020 | 83 | 0.250 |
Why?
|
| Alanine | 6 | 2009 | 184 | 0.240 |
Why?
|
| Protein Folding | 3 | 2001 | 222 | 0.240 |
Why?
|
| Virulence Factors | 2 | 2020 | 187 | 0.230 |
Why?
|
| Glutamic Acid | 3 | 2015 | 209 | 0.230 |
Why?
|
| Rotavirus | 3 | 2014 | 503 | 0.220 |
Why?
|
| Azabicyclo Compounds | 1 | 2024 | 21 | 0.210 |
Why?
|
| Morpholines | 1 | 2024 | 64 | 0.210 |
Why?
|
| Gene Dosage | 1 | 2025 | 456 | 0.210 |
Why?
|
| Viral Vaccines | 2 | 2025 | 345 | 0.210 |
Why?
|
| Biocatalysis | 2 | 2015 | 36 | 0.210 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2005 | 180 | 0.210 |
Why?
|
| Biology | 1 | 2023 | 28 | 0.200 |
Why?
|
| Cross Reactions | 2 | 2014 | 193 | 0.200 |
Why?
|
| Hydrogen-Ion Concentration | 4 | 2019 | 457 | 0.200 |
Why?
|
| Protein Sorting Signals | 3 | 2011 | 40 | 0.200 |
Why?
|
| Drug Combinations | 1 | 2024 | 284 | 0.200 |
Why?
|
| Enzymes | 1 | 2003 | 48 | 0.200 |
Why?
|
| Host-Pathogen Interactions | 1 | 2025 | 265 | 0.190 |
Why?
|
| Aspartic Acid | 2 | 2001 | 85 | 0.190 |
Why?
|
| Enterobacter cloacae | 3 | 2015 | 13 | 0.190 |
Why?
|
| Capsid Proteins | 2 | 2020 | 195 | 0.190 |
Why?
|
| Combinatorial Chemistry Techniques | 1 | 2002 | 15 | 0.190 |
Why?
|
| Feces | 3 | 2015 | 780 | 0.190 |
Why?
|
| Quantum Theory | 1 | 2021 | 22 | 0.180 |
Why?
|
| Gram-Positive Bacterial Infections | 1 | 2002 | 80 | 0.180 |
Why?
|
| Genome, Viral | 2 | 2020 | 184 | 0.180 |
Why?
|
| Promoter Regions, Genetic | 2 | 2008 | 1420 | 0.180 |
Why?
|
| Antibodies | 2 | 2020 | 371 | 0.180 |
Why?
|
| Cefazolin | 1 | 2021 | 20 | 0.180 |
Why?
|
| Protein Conformation, beta-Strand | 1 | 2020 | 15 | 0.170 |
Why?
|
| Protein Conformation, alpha-Helical | 1 | 2020 | 17 | 0.170 |
Why?
|
| Phylogeny | 4 | 2023 | 780 | 0.170 |
Why?
|
| Genomics | 2 | 2008 | 1677 | 0.170 |
Why?
|
| Bacterial Outer Membrane Proteins | 5 | 2010 | 116 | 0.170 |
Why?
|
| Lac Repressors | 1 | 2020 | 15 | 0.170 |
Why?
|
| Arabinose | 1 | 2000 | 25 | 0.170 |
Why?
|
| Leucine Zippers | 1 | 2020 | 18 | 0.170 |
Why?
|
| Macrocyclic Compounds | 1 | 2020 | 12 | 0.170 |
Why?
|
| Molecular Dynamics Simulation | 2 | 2021 | 117 | 0.170 |
Why?
|
| Vimentin | 1 | 2020 | 69 | 0.170 |
Why?
|
| Peptidomimetics | 1 | 2020 | 13 | 0.170 |
Why?
|
| P-Selectin | 1 | 2020 | 74 | 0.170 |
Why?
|
| Repressor Proteins | 4 | 2019 | 872 | 0.170 |
Why?
|
| Pharyngitis | 1 | 2020 | 34 | 0.170 |
Why?
|
| Animals | 22 | 2021 | 36215 | 0.170 |
Why?
|
| Colorimetry | 1 | 2020 | 18 | 0.160 |
Why?
|
| Endotoxemia | 1 | 2020 | 55 | 0.160 |
Why?
|
| Disseminated Intravascular Coagulation | 1 | 2020 | 67 | 0.160 |
Why?
|
| Neisseria gonorrhoeae | 1 | 2019 | 16 | 0.160 |
Why?
|
| DNA Copy Number Variations | 1 | 2025 | 1036 | 0.160 |
Why?
|
| Cell Adhesion | 1 | 2020 | 340 | 0.160 |
Why?
|
| DNA-Binding Proteins | 1 | 2008 | 2145 | 0.160 |
Why?
|
| Peptide Fragments | 3 | 2007 | 828 | 0.160 |
Why?
|
| Leukocytes | 1 | 2020 | 216 | 0.150 |
Why?
|
| Biosensing Techniques | 1 | 2020 | 69 | 0.150 |
Why?
|
| Calorimetry | 4 | 2014 | 63 | 0.150 |
Why?
|
| rho GTP-Binding Proteins | 1 | 2019 | 69 | 0.150 |
Why?
|
| Drug Design | 1 | 2020 | 168 | 0.150 |
Why?
|
| Antiviral Agents | 1 | 2025 | 822 | 0.150 |
Why?
|
| Histidine | 1 | 2019 | 75 | 0.150 |
Why?
|
| Nuclear Receptor Coactivator 2 | 3 | 2015 | 207 | 0.150 |
Why?
|
| Conserved Sequence | 2 | 2016 | 299 | 0.150 |
Why?
|
| Saccharomyces cerevisiae | 4 | 1994 | 440 | 0.150 |
Why?
|
| Viral Nonstructural Proteins | 2 | 2012 | 194 | 0.150 |
Why?
|
| Phenylalanine | 1 | 1999 | 134 | 0.150 |
Why?
|
| Epistasis, Genetic | 1 | 2018 | 103 | 0.140 |
Why?
|
| Molecular Imaging | 1 | 2018 | 65 | 0.140 |
Why?
|
| Membrane Glycoproteins | 1 | 2020 | 431 | 0.140 |
Why?
|
| Terminology as Topic | 1 | 2020 | 226 | 0.140 |
Why?
|
| Staphylococcal Infections | 2 | 2021 | 573 | 0.140 |
Why?
|
| MAP Kinase Signaling System | 1 | 2019 | 323 | 0.140 |
Why?
|
| Apoenzymes | 1 | 2017 | 3 | 0.140 |
Why?
|
| Benzimidazoles | 2 | 2016 | 136 | 0.140 |
Why?
|
| Glutathione | 1 | 2018 | 198 | 0.140 |
Why?
|
| Proteolysis | 2 | 2019 | 198 | 0.140 |
Why?
|
| Oximes | 1 | 2017 | 56 | 0.130 |
Why?
|
| Proteins | 1 | 2003 | 1090 | 0.130 |
Why?
|
| DNA Mutational Analysis | 3 | 2012 | 841 | 0.130 |
Why?
|
| Aztreonam | 1 | 1996 | 4 | 0.130 |
Why?
|
| Aeromonas hydrophila | 1 | 2016 | 3 | 0.130 |
Why?
|
| Microfilament Proteins | 1 | 2019 | 289 | 0.130 |
Why?
|
| Carcinogenesis | 1 | 2019 | 361 | 0.130 |
Why?
|
| Polymerase Chain Reaction | 5 | 2015 | 1582 | 0.130 |
Why?
|
| Oligopeptides | 1 | 2016 | 121 | 0.130 |
Why?
|
| Tyrosine | 2 | 2015 | 157 | 0.130 |
Why?
|
| Cross Infection | 1 | 2020 | 344 | 0.130 |
Why?
|
| Molecular Conformation | 3 | 2025 | 111 | 0.130 |
Why?
|
| Hydrogen Bonding | 4 | 2012 | 87 | 0.130 |
Why?
|
| Hydrazones | 1 | 2016 | 19 | 0.120 |
Why?
|
| Temperature | 2 | 2010 | 326 | 0.120 |
Why?
|
| Point Mutation | 1 | 2017 | 358 | 0.120 |
Why?
|
| Polymorphism, Genetic | 2 | 2008 | 814 | 0.120 |
Why?
|
| Reproducibility of Results | 3 | 2020 | 3044 | 0.120 |
Why?
|
| Proteus Infections | 1 | 1995 | 7 | 0.120 |
Why?
|
| Proteus mirabilis | 1 | 1995 | 12 | 0.120 |
Why?
|
| Iodides | 1 | 2015 | 15 | 0.120 |
Why?
|
| Betaherpesvirinae | 1 | 2015 | 5 | 0.120 |
Why?
|
| DNA, Viral | 1 | 2016 | 496 | 0.120 |
Why?
|
| Endangered Species | 1 | 2015 | 18 | 0.120 |
Why?
|
| Antibodies, Anti-Idiotypic | 1 | 2015 | 40 | 0.120 |
Why?
|
| Thrombosis | 1 | 2020 | 544 | 0.110 |
Why?
|
| GATA2 Transcription Factor | 1 | 2014 | 47 | 0.110 |
Why?
|
| Trichothecenes | 1 | 2014 | 4 | 0.110 |
Why?
|
| DNA, Fungal | 3 | 1991 | 78 | 0.110 |
Why?
|
| Elephants | 1 | 2015 | 45 | 0.110 |
Why?
|
| Genotype | 2 | 2019 | 2720 | 0.110 |
Why?
|
| Nuclear Receptor Coactivators | 1 | 2014 | 76 | 0.110 |
Why?
|
| Solubility | 2 | 2012 | 140 | 0.110 |
Why?
|
| Models, Chemical | 2 | 2004 | 90 | 0.110 |
Why?
|
| Bufanolides | 1 | 2014 | 17 | 0.110 |
Why?
|
| HeLa Cells | 4 | 2018 | 839 | 0.110 |
Why?
|
| Herpesviridae Infections | 1 | 2015 | 146 | 0.100 |
Why?
|
| Protein Stability | 2 | 2011 | 175 | 0.100 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2014 | 111 | 0.100 |
Why?
|
| Water | 2 | 2012 | 199 | 0.100 |
Why?
|
| Autism Spectrum Disorder | 1 | 2019 | 430 | 0.100 |
Why?
|
| Nucleoside-Triphosphatase | 1 | 2012 | 2 | 0.100 |
Why?
|
| Nerve Tissue Proteins | 1 | 2019 | 1152 | 0.100 |
Why?
|
| Carboxylic Acids | 1 | 2012 | 25 | 0.100 |
Why?
|
| Anthrax Vaccines | 1 | 2012 | 26 | 0.100 |
Why?
|
| Viral Proteins | 1 | 2014 | 360 | 0.100 |
Why?
|
| Down-Regulation | 2 | 2011 | 714 | 0.100 |
Why?
|
| Enterobacteriaceae | 1 | 1992 | 41 | 0.100 |
Why?
|
| Mutation Rate | 1 | 2012 | 72 | 0.100 |
Why?
|
| Metalloendopeptidases | 1 | 2012 | 103 | 0.100 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2014 | 230 | 0.090 |
Why?
|
| Gossypol | 1 | 2011 | 5 | 0.090 |
Why?
|
| Thiazoles | 1 | 2012 | 104 | 0.090 |
Why?
|
| Norwalk virus | 1 | 2013 | 170 | 0.090 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2021 | 1714 | 0.090 |
Why?
|
| Exotoxins | 1 | 2011 | 45 | 0.090 |
Why?
|
| Receptors, Androgen | 1 | 2014 | 433 | 0.090 |
Why?
|
| Models, Genetic | 3 | 2010 | 786 | 0.090 |
Why?
|
| Cyclic GMP-Dependent Protein Kinases | 1 | 2011 | 19 | 0.090 |
Why?
|
| Cell Line, Tumor | 5 | 2019 | 3794 | 0.090 |
Why?
|
| Cyclic GMP | 1 | 2011 | 99 | 0.090 |
Why?
|
| Stereoisomerism | 2 | 2024 | 122 | 0.080 |
Why?
|
| Cyclic AMP | 1 | 2011 | 249 | 0.080 |
Why?
|
| Mice | 10 | 2020 | 18935 | 0.080 |
Why?
|
| DNA Replication | 2 | 1991 | 358 | 0.080 |
Why?
|
| Sensitivity and Specificity | 2 | 2013 | 2139 | 0.080 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 2 | 2015 | 304 | 0.080 |
Why?
|
| Transcription, Genetic | 5 | 2016 | 1757 | 0.080 |
Why?
|
| Inhibitory Concentration 50 | 2 | 2011 | 89 | 0.080 |
Why?
|
| Biomarkers | 1 | 2018 | 3416 | 0.080 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2008 | 54 | 0.070 |
Why?
|
| RNA | 1 | 2012 | 606 | 0.070 |
Why?
|
| Microbial Viability | 1 | 2008 | 43 | 0.070 |
Why?
|
| Regulon | 1 | 2008 | 11 | 0.070 |
Why?
|
| Interferometry | 2 | 2020 | 25 | 0.070 |
Why?
|
| Fibronectins | 1 | 2008 | 110 | 0.070 |
Why?
|
| Laminin | 1 | 2008 | 72 | 0.070 |
Why?
|
| RNA-Binding Proteins | 1 | 2012 | 622 | 0.070 |
Why?
|
| Molecular Docking Simulation | 2 | 2020 | 127 | 0.070 |
Why?
|
| Bacterial Physiological Phenomena | 1 | 2007 | 21 | 0.070 |
Why?
|
| Antibody Specificity | 1 | 2007 | 198 | 0.070 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2008 | 1067 | 0.070 |
Why?
|
| Multiprotein Complexes | 1 | 2008 | 219 | 0.070 |
Why?
|
| Toxins, Biological | 1 | 2007 | 71 | 0.070 |
Why?
|
| Gene Transfer, Horizontal | 1 | 2007 | 51 | 0.070 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2015 | 1325 | 0.070 |
Why?
|
| Clavulanic Acid | 2 | 2004 | 7 | 0.060 |
Why?
|
| Gene Amplification | 2 | 2008 | 245 | 0.060 |
Why?
|
| beta Karyopherins | 1 | 2006 | 15 | 0.060 |
Why?
|
| Genes, Fungal | 1 | 1986 | 64 | 0.060 |
Why?
|
| Nuclear Pore Complex Proteins | 1 | 2006 | 17 | 0.060 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2000 | 805 | 0.060 |
Why?
|
| Movement | 1 | 2007 | 166 | 0.060 |
Why?
|
| Klebsiella | 1 | 2025 | 10 | 0.060 |
Why?
|
| Enterobacter | 1 | 2025 | 15 | 0.060 |
Why?
|
| Neoplasms | 3 | 2015 | 2989 | 0.060 |
Why?
|
| Glycoproteins | 1 | 2007 | 380 | 0.060 |
Why?
|
| Signal Transduction | 3 | 2014 | 4918 | 0.060 |
Why?
|
| Crystallography | 1 | 2025 | 40 | 0.060 |
Why?
|
| DNA, Recombinant | 2 | 2000 | 106 | 0.060 |
Why?
|
| Gene Duplication | 1 | 2007 | 372 | 0.060 |
Why?
|
| Electron Spin Resonance Spectroscopy | 1 | 2004 | 18 | 0.060 |
Why?
|
| In Vitro Techniques | 1 | 2006 | 960 | 0.060 |
Why?
|
| Spin Labels | 1 | 2004 | 38 | 0.050 |
Why?
|
| Esters | 1 | 2024 | 35 | 0.050 |
Why?
|
| Chemistry, Pharmaceutical | 1 | 2024 | 56 | 0.050 |
Why?
|
| Proteomics | 1 | 2008 | 605 | 0.050 |
Why?
|
| MCF-7 Cells | 2 | 2015 | 233 | 0.050 |
Why?
|
| Spectrophotometry | 1 | 2004 | 59 | 0.050 |
Why?
|
| Amino Acid Motifs | 1 | 2004 | 212 | 0.050 |
Why?
|
| Chelating Agents | 1 | 2004 | 46 | 0.050 |
Why?
|
| Bacteria | 2 | 2002 | 536 | 0.050 |
Why?
|
| Ribosomal Proteins | 1 | 2004 | 76 | 0.050 |
Why?
|
| Cell Nucleus | 1 | 2006 | 689 | 0.050 |
Why?
|
| Peroxidases | 1 | 1983 | 29 | 0.050 |
Why?
|
| Catalase | 1 | 1983 | 65 | 0.050 |
Why?
|
| Anthrax | 1 | 2003 | 31 | 0.050 |
Why?
|
| Directed Molecular Evolution | 1 | 2003 | 11 | 0.050 |
Why?
|
| Gene Deletion | 3 | 2012 | 806 | 0.050 |
Why?
|
| Computational Biology | 1 | 2008 | 887 | 0.050 |
Why?
|
| Indicators and Reagents | 1 | 2003 | 52 | 0.050 |
Why?
|
| Disulfides | 1 | 2003 | 84 | 0.050 |
Why?
|
| Sequence Deletion | 1 | 2005 | 541 | 0.050 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2016 | 384 | 0.050 |
Why?
|
| Lysine | 1 | 2003 | 207 | 0.050 |
Why?
|
| Solvents | 1 | 2022 | 46 | 0.050 |
Why?
|
| Superoxide Dismutase | 1 | 1983 | 180 | 0.050 |
Why?
|
| Drug Delivery Systems | 1 | 2004 | 232 | 0.050 |
Why?
|
| Sulbactam | 2 | 2000 | 5 | 0.050 |
Why?
|
| Child | 2 | 2022 | 25846 | 0.050 |
Why?
|
| Chromosomes, Artificial, Bacterial | 1 | 2002 | 94 | 0.050 |
Why?
|
| Surface Plasmon Resonance | 2 | 2014 | 52 | 0.050 |
Why?
|
| X-Ray Diffraction | 1 | 2001 | 105 | 0.050 |
Why?
|
| Antineoplastic Agents | 1 | 2011 | 1849 | 0.050 |
Why?
|
| Gram-Negative Bacterial Infections | 1 | 2002 | 92 | 0.050 |
Why?
|
| Multigene Family | 2 | 2008 | 321 | 0.050 |
Why?
|
| Gene Expression Profiling | 2 | 2008 | 1915 | 0.040 |
Why?
|
| Methicillin | 1 | 2021 | 43 | 0.040 |
Why?
|
| Isoenzymes | 1 | 2001 | 228 | 0.040 |
Why?
|
| Cell Survival | 2 | 2015 | 884 | 0.040 |
Why?
|
| Complement Inactivator Proteins | 1 | 2000 | 4 | 0.040 |
Why?
|
| Latin America | 1 | 2021 | 98 | 0.040 |
Why?
|
| Iron | 1 | 2004 | 304 | 0.040 |
Why?
|
| AraC Transcription Factor | 1 | 2000 | 3 | 0.040 |
Why?
|
| Genetic Engineering | 1 | 2021 | 165 | 0.040 |
Why?
|
| Penicillin G | 1 | 2000 | 19 | 0.040 |
Why?
|
| Endothelium | 1 | 2020 | 70 | 0.040 |
Why?
|
| Macaca fascicularis | 1 | 2020 | 88 | 0.040 |
Why?
|
| Mass Spectrometry | 1 | 2001 | 367 | 0.040 |
Why?
|
| Healthy Volunteers | 1 | 2020 | 153 | 0.040 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 1 | 2020 | 108 | 0.040 |
Why?
|
| Enzyme Activation | 1 | 2021 | 640 | 0.040 |
Why?
|
| raf Kinases | 1 | 2019 | 6 | 0.040 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2021 | 135 | 0.040 |
Why?
|
| Taurodeoxycholic Acid | 1 | 2019 | 4 | 0.040 |
Why?
|
| Fibrin | 1 | 2020 | 64 | 0.040 |
Why?
|
| 3T3 Cells | 1 | 2019 | 127 | 0.040 |
Why?
|
| Chenodeoxycholic Acid | 1 | 2019 | 14 | 0.040 |
Why?
|
| Blotting, Western | 3 | 2014 | 1136 | 0.040 |
Why?
|
| Disease Models, Animal | 2 | 2020 | 4758 | 0.040 |
Why?
|
| Computer Simulation | 3 | 2012 | 708 | 0.040 |
Why?
|
| International Cooperation | 1 | 2020 | 166 | 0.040 |
Why?
|
| Post-Synaptic Density | 1 | 2019 | 11 | 0.040 |
Why?
|
| Terminator Regions, Genetic | 1 | 1998 | 8 | 0.040 |
Why?
|
| Intracellular Space | 1 | 2018 | 51 | 0.040 |
Why?
|
| Rec A Recombinases | 1 | 1998 | 26 | 0.040 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2019 | 177 | 0.040 |
Why?
|
| Female | 9 | 2020 | 71459 | 0.040 |
Why?
|
| von Willebrand Factor | 1 | 2020 | 205 | 0.040 |
Why?
|
| Consensus | 1 | 2022 | 724 | 0.040 |
Why?
|
| Mice, Nude | 1 | 2019 | 780 | 0.040 |
Why?
|
| Oxidation-Reduction | 1 | 2018 | 464 | 0.030 |
Why?
|
| Drosophila melanogaster | 1 | 1983 | 844 | 0.030 |
Why?
|
| Fluorescent Dyes | 1 | 2018 | 268 | 0.030 |
Why?
|
| Cytoskeletal Proteins | 1 | 2019 | 283 | 0.030 |
Why?
|
| Microscopy, Confocal | 1 | 2018 | 366 | 0.030 |
Why?
|
| United States | 1 | 2013 | 11726 | 0.030 |
Why?
|
| Cell Proliferation | 2 | 2014 | 2559 | 0.030 |
Why?
|
| Virus Attachment | 1 | 2016 | 41 | 0.030 |
Why?
|
| Immunoglobulin G | 2 | 2015 | 789 | 0.030 |
Why?
|
| Surface Properties | 1 | 1996 | 96 | 0.030 |
Why?
|
| Membrane Proteins | 1 | 2004 | 1611 | 0.030 |
Why?
|
| Cell Line | 2 | 2014 | 2853 | 0.030 |
Why?
|
| Cyclohexanones | 1 | 2015 | 19 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2021 | 3131 | 0.030 |
Why?
|
| Male | 7 | 2020 | 65532 | 0.030 |
Why?
|
| Interferons | 1 | 2016 | 144 | 0.030 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2015 | 111 | 0.030 |
Why?
|
| Polysaccharides | 1 | 2016 | 152 | 0.030 |
Why?
|
| Chromatography, Gel | 1 | 2015 | 96 | 0.030 |
Why?
|
| Autistic Disorder | 1 | 2019 | 379 | 0.030 |
Why?
|
| Virosomes | 1 | 2014 | 4 | 0.030 |
Why?
|
| Immunoblotting | 1 | 2015 | 316 | 0.030 |
Why?
|
| Antibody Affinity | 1 | 2014 | 41 | 0.030 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2019 | 625 | 0.030 |
Why?
|
| Enterobacteriaceae Infections | 1 | 2015 | 59 | 0.030 |
Why?
|
| MutS DNA Mismatch-Binding Protein | 1 | 2014 | 9 | 0.030 |
Why?
|
| Hepatocyte Nuclear Factor 3-alpha | 1 | 2014 | 50 | 0.030 |
Why?
|
| Threonine | 1 | 1994 | 63 | 0.030 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2015 | 130 | 0.030 |
Why?
|
| DNA Transposable Elements | 2 | 1992 | 189 | 0.030 |
Why?
|
| Tumor Burden | 1 | 2015 | 256 | 0.030 |
Why?
|
| Enzyme Precursors | 1 | 1994 | 26 | 0.030 |
Why?
|
| Immunoglobulin M | 1 | 2015 | 216 | 0.030 |
Why?
|
| Enzyme Induction | 1 | 1994 | 101 | 0.030 |
Why?
|
| Immunoglobulin A | 1 | 2015 | 215 | 0.030 |
Why?
|
| Methionine | 1 | 1994 | 105 | 0.030 |
Why?
|
| Protein-Arginine N-Methyltransferases | 1 | 2014 | 46 | 0.030 |
Why?
|
| p300-CBP Transcription Factors | 1 | 2014 | 52 | 0.030 |
Why?
|
| Receptors, Peptide | 1 | 1994 | 54 | 0.030 |
Why?
|
| Pyridines | 1 | 2015 | 250 | 0.030 |
Why?
|
| Digoxin | 1 | 2014 | 43 | 0.030 |
Why?
|
| Bacterial Adhesion | 1 | 1994 | 106 | 0.030 |
Why?
|
| RNA Interference | 1 | 2015 | 546 | 0.030 |
Why?
|
| Escherichia coli Infections | 1 | 2014 | 195 | 0.020 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2014 | 323 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2015 | 824 | 0.020 |
Why?
|
| Sequence Homology | 1 | 1992 | 64 | 0.020 |
Why?
|
| Genome-Wide Association Study | 1 | 2020 | 1838 | 0.020 |
Why?
|
| Bacillus | 1 | 1992 | 37 | 0.020 |
Why?
|
| Crystallization | 1 | 2012 | 88 | 0.020 |
Why?
|
| Mice, SCID | 1 | 2014 | 614 | 0.020 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2015 | 294 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2015 | 527 | 0.020 |
Why?
|
| Inflammation | 1 | 2020 | 1557 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2015 | 1013 | 0.020 |
Why?
|
| Leupeptins | 1 | 2011 | 26 | 0.020 |
Why?
|
| Rats | 1 | 2019 | 3851 | 0.020 |
Why?
|
| Replicon | 1 | 1991 | 6 | 0.020 |
Why?
|
| Genetic Variation | 1 | 2019 | 1597 | 0.020 |
Why?
|
| DNA, Circular | 1 | 1991 | 18 | 0.020 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 2011 | 45 | 0.020 |
Why?
|
| Cystic Fibrosis | 1 | 2014 | 266 | 0.020 |
Why?
|
| Proteasome Inhibitors | 1 | 2011 | 66 | 0.020 |
Why?
|
| Serotyping | 2 | 2002 | 178 | 0.020 |
Why?
|
| Random Allocation | 1 | 1992 | 443 | 0.020 |
Why?
|
| Apoproteins | 1 | 2011 | 18 | 0.020 |
Why?
|
| Cyclic AMP-Dependent Protein Kinase RIalpha Subunit | 1 | 2011 | 10 | 0.020 |
Why?
|
| Structural Homology, Protein | 1 | 2011 | 27 | 0.020 |
Why?
|
| Drug Synergism | 1 | 2011 | 238 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2000 | 2651 | 0.020 |
Why?
|
| Cyclic AMP Receptor Protein | 1 | 2010 | 1 | 0.020 |
Why?
|
| Cyclic GMP-Dependent Protein Kinase Type I | 1 | 2011 | 18 | 0.020 |
Why?
|
| Chromatin | 1 | 2014 | 617 | 0.020 |
Why?
|
| Virulence | 1 | 2011 | 278 | 0.020 |
Why?
|
| Macaca mulatta | 1 | 2012 | 513 | 0.020 |
Why?
|
| Lac Operon | 1 | 2010 | 96 | 0.020 |
Why?
|
| beta-Galactosidase | 1 | 2010 | 148 | 0.020 |
Why?
|
| Heme | 1 | 2010 | 53 | 0.020 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2011 | 277 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 2015 | 868 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2012 | 1083 | 0.020 |
Why?
|
| Genes, Reporter | 1 | 2010 | 391 | 0.020 |
Why?
|
| Neoplasm Proteins | 1 | 2014 | 712 | 0.020 |
Why?
|
| Bacterial Infections | 1 | 1992 | 329 | 0.020 |
Why?
|
| Guanidine | 2 | 2001 | 10 | 0.020 |
Why?
|
| Protein Denaturation | 2 | 2001 | 52 | 0.020 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2008 | 65 | 0.020 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2008 | 69 | 0.020 |
Why?
|
| Treponemal Infections | 1 | 2008 | 3 | 0.020 |
Why?
|
| Microscopy, Immunoelectron | 1 | 2008 | 22 | 0.020 |
Why?
|
| Aerobiosis | 1 | 2008 | 13 | 0.020 |
Why?
|
| Anaerobiosis | 1 | 2008 | 15 | 0.020 |
Why?
|
| Hot Temperature | 1 | 2008 | 145 | 0.020 |
Why?
|
| Quality Control | 1 | 2008 | 123 | 0.020 |
Why?
|
| DNA Fingerprinting | 1 | 2008 | 107 | 0.020 |
Why?
|
| Operon | 1 | 2008 | 54 | 0.020 |
Why?
|
| Estrogen Receptor alpha | 1 | 2011 | 478 | 0.020 |
Why?
|
| Bacterial Vaccines | 1 | 2008 | 103 | 0.020 |
Why?
|
| Vaccines, Subunit | 1 | 2008 | 70 | 0.020 |
Why?
|
| Flagella | 1 | 2007 | 29 | 0.020 |
Why?
|
| Bacillus subtilis | 1 | 2007 | 50 | 0.020 |
Why?
|
| Oxygen | 1 | 2010 | 578 | 0.020 |
Why?
|
| Species Specificity | 1 | 2008 | 563 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2008 | 334 | 0.020 |
Why?
|
| Genes, Regulator | 1 | 1986 | 57 | 0.020 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1986 | 294 | 0.020 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2006 | 130 | 0.020 |
Why?
|
| Serine-Type D-Ala-D-Ala Carboxypeptidase | 1 | 2005 | 4 | 0.010 |
Why?
|
| Chromosome Mapping | 1 | 2008 | 1118 | 0.010 |
Why?
|
| RNA, Bacterial | 1 | 2005 | 56 | 0.010 |
Why?
|
| Chromosome Deletion | 1 | 1988 | 664 | 0.010 |
Why?
|
| Prognosis | 1 | 2014 | 5042 | 0.010 |
Why?
|
| Buffers | 1 | 2004 | 32 | 0.010 |
Why?
|
| Dimethyl Sulfoxide | 1 | 2004 | 18 | 0.010 |
Why?
|
| Freezing | 1 | 2004 | 29 | 0.010 |
Why?
|
| Solutions | 1 | 2004 | 67 | 0.010 |
Why?
|
| Amitrole | 1 | 1983 | 2 | 0.010 |
Why?
|
| Pupa | 1 | 1983 | 23 | 0.010 |
Why?
|
| Breast Neoplasms | 1 | 2016 | 2762 | 0.010 |
Why?
|
| Streptococcal Vaccines | 1 | 2002 | 18 | 0.010 |
Why?
|
| Hydrogen Peroxide | 1 | 1983 | 126 | 0.010 |
Why?
|
| Larva | 1 | 1983 | 254 | 0.010 |
Why?
|
| Immune Sera | 1 | 2002 | 93 | 0.010 |
Why?
|
| Hemolysis | 1 | 2002 | 114 | 0.010 |
Why?
|
| Immunization | 1 | 2002 | 315 | 0.010 |
Why?
|
| Periplasm | 1 | 2001 | 9 | 0.010 |
Why?
|
| Inclusion Bodies | 1 | 2001 | 48 | 0.010 |
Why?
|
| Phenotype | 1 | 2010 | 4577 | 0.010 |
Why?
|
| Circular Dichroism | 1 | 2000 | 86 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2002 | 814 | 0.010 |
Why?
|
| Young Adult | 1 | 2014 | 9921 | 0.010 |
Why?
|
| Sex Factors | 1 | 1983 | 1350 | 0.010 |
Why?
|
| Middle Aged | 2 | 2000 | 28956 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2008 | 2855 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2005 | 2877 | 0.010 |
Why?
|
| Helicobacter pylori | 1 | 2007 | 1174 | 0.010 |
Why?
|
| Adult | 2 | 2014 | 31651 | 0.010 |
Why?
|
| Isomerism | 1 | 1996 | 28 | 0.010 |
Why?
|
| Guanidines | 1 | 1996 | 25 | 0.010 |
Why?
|
| Spectrometry, Fluorescence | 1 | 1996 | 87 | 0.010 |
Why?
|
| Aging | 1 | 1983 | 1280 | 0.010 |
Why?
|
| Carrier Proteins | 1 | 2000 | 1072 | 0.010 |
Why?
|
| Receptors, Mating Factor | 1 | 1994 | 2 | 0.010 |
Why?
|
| Mating Factor | 1 | 1994 | 5 | 0.010 |
Why?
|
| Hemagglutination Tests | 1 | 1994 | 11 | 0.010 |
Why?
|
| Adhesins, Escherichia coli | 1 | 1994 | 20 | 0.010 |
Why?
|
| Genetic Complementation Test | 1 | 1994 | 90 | 0.010 |
Why?
|
| Fimbriae, Bacterial | 1 | 1994 | 44 | 0.010 |
Why?
|
| Oligonucleotides | 1 | 1994 | 94 | 0.010 |
Why?
|
| Sheep | 1 | 1994 | 232 | 0.010 |
Why?
|
| Fungal Proteins | 1 | 1994 | 143 | 0.010 |
Why?
|
| GTP-Binding Proteins | 1 | 1994 | 187 | 0.010 |
Why?
|
| Cytoplasm | 1 | 1994 | 301 | 0.010 |
Why?
|
| Transformation, Genetic | 1 | 1991 | 36 | 0.010 |
Why?
|
| Chromosomes, Fungal | 1 | 1991 | 49 | 0.010 |
Why?
|
| Restriction Mapping | 1 | 1991 | 191 | 0.010 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 1991 | 141 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2000 | 7137 | 0.000 |
Why?
|
| Infant | 1 | 2000 | 13230 | 0.000 |
Why?
|
| Child, Preschool | 1 | 2000 | 14859 | 0.000 |
Why?
|
| Adolescent | 1 | 2000 | 20551 | 0.000 |
Why?
|
| Aged | 1 | 2000 | 21479 | 0.000 |
Why?
|